Pearls and pitfalls for principal investigators
Interested in becoming a principal researcher? Read this first.
Directly targeting pathology: A novel approach to treating glaucoma
Rho kinase inhibitors are intriguing in that they work directly on the pathogenic mechanism of abnormally elevated IOP, increased resistance to trabecular outflow.
2 Clarke Drive Cranbury, NJ 08512